Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7501 Fannin St Ste 750
Houston, TX 77054Phone+1 713-979-1190- Is this information wrong?
Education & Training
Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1987- Baylor College of MedicineResidency, Internal Medicine, 1981 - 1984
- Baylor College of MedicineClass of 1981
Certifications & Licensure
FL State Medical License 2023 - Present
UT State Medical License 2023 - 2026
IL State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
ME State Medical License 2023 - 2026
WI State Medical License 2023 - 2025
NC State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsEmployer-mandated obstructive sleep apnea treatment and healthcare cost savings among truckersStephen V. Burks, Jon E. Anderson, Bibhudutta Panda, Rebecca Haider, Tim Ginader, Nicole Sandback, Darya Y. Pokutnaya, Derek Toso, Natalie Hughes, Humza S. Haider, Res...> ;Sleep. 2020 Apr 15
- 58 citationsNonadherence with Employer-Mandated Sleep Apnea Treatment and Increased Risk of Serious Truck Crashes.Stephen V. Burks, Jon E. Anderson, Matthew Bombyk, Rebecca Haider, Derek Ganzhorn, Xueyang Jiao, Connor Lewis, Andrew Lexvold, Hong Liu, Jiachen Ning, Alice Toll, Jeff...> ;Sleep. 2016 May 1
- 51 citationsEmployer-Mandated Sleep Apnea Screening and Diagnosis in Commercial DriversMark Berger, Vasileia Varvarigou, Albert Rielly, Charles A. Czeisler, Atul Malhotra, Stefanos N. Kales> ;Journal of Occupational and Environmental Medicine. 2012 Aug 1
Press Mentions
$GNPX Target PTs 7 and HigherJanuary 4th, 2022- Genprex Announces First Patient Dosed in Phase 2a Expansion of Acclaim-1 Clinical Study of Reqorsa® Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung CancerFebruary 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
